Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis p53'

Search results for: 'research area apoptosis p53'

Items 31-40 of 47

Page
per page
  1. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  2. Agouti-related Protein (AGRP) (25-82), human
    A1134 Agouti-related Protein (AGRP) (25-82), human
    Target: Melanocortin (MC) Receptors
    Summary: Agouti-related peptide(25-82)
      insoluble in EtOH; insoluble in DMSO; ≥100 mg/mL
  3. DMXAA (Vadimezan)
    A8233 DMXAA (Vadimezan)
     2 Citation
    Target: DT-diaphorases
    Summary: Tumnor vascular disrupting agent, apoptosis inducer
      insoluble in H2O; insoluble in EtOH; ≥14.1 mg/mL
  4. Elesclomol (STA-4783)
    A4386 Elesclomol (STA-4783)
     3 Citation
    Summary: Oxidative stress/apoptosis inducer,potent and novel
      insoluble in H2O; ≥20.15 mg/mL
  5. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL
  6. GKT137831
    B4763 GKT137831
     1 Citation
    Target: NADPH Oxidases
    Summary: dual NADPH oxidase Nox1/Nox4 inhibitor
      ≥39.5 mg/mL
  7. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  8. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  9. Puromycin aminonucleoside
    A3740 Puromycin aminonucleoside
     1 Citation
    Summary: Aminonucleoside portion of the antibiotic puromycin
      ≥14.45 mg/mL
  10. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL

Items 31-40 of 47

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Natural Products 1 item
Reversibility
  1. Irreversible 2item
Target
  1. Caspases 5item
  2. Cyclin-Dependent Kinases 2item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 3item
  5. Inhibitor of apoptosis proteins (IAP) 2item
  6. Bcl-2 4item
  7. Raf 1 item
  8. Bcl-xl 1 item
  9. MDM2 2item
  10. AP-1 1 item
  11. DT-diaphorases 1 item
  12. GSK-3 1 item
  13. VEGFR 2item
  14. PDGFR 1 item
  15. c-Kit 1 item
  16. RET 1 item
  17. Mcl-1 1 item
  18. Sir2-like Family Deacetylases (Sirtuins) 1 item
  19. Deubiquitinating enzymes (DUBs) 1 item
  20. STAT 1 item
  21. RIP kinases 1 item
  22. JAK 2item
  23. HSP90 1 item
  24. Survivin 1 item
  25. Ubiquitin-specific proteases 1 item
  26. Melanocortin (MC) Receptors 1 item
  27. MK2 1 item
  28. Fatty-acid-binding proteins (FABPs) 1 item
  29. NADPH Oxidases 1 item
  30. MAGL 1 item
  31. TRP Channel 1 item
  32. Cdc7 1 item
  33. angiogenesis 1 item
  34. p53-MDM2 interaction 1 item
  35. PC-PLC 1 item
  36. PKD 1 item
  37. Bcl-w 1 item
  38. Sirtuin 1 item
Related Disease
  1. Autoimmune Diseases 1 item
  2. Breast Cancer 10item
  3. Cancer 30item
  4. Chronic Lymphocytic Leukemia 1 item
  5. Chronic Myeloproliferative Disorders 1 item
  6. Colon Cancer 3item
  7. Colon Carcinoma 1 item
  8. Colorectal Cancer 3item
  9. Glioblastoma 4item
  10. Hepatocellular Carcinoma 1 item
  11. Inflammatory Diseases 2item
  12. Leukemia 1 item
  13. Lung Cancer 1 item
  14. Lymphoma 3item
  15. Melanoma 4item
  16. Multiple Myeloma 1 item
  17. Myelofibrosis 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 2item
  21. Ovarian Cancer 1 item
  22. Pain Relief 1 item
  23. Pancreatic Cancer 3item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Rheumatoid Arthritis 2item
  27. Soft Tissue Sarcoma 1 item
  28. Testicular Cancer 1 item
  29. Type 2 Diabetes 2item